Technetium Tc 99M (Pyro- And Trimeta-) Phosphates

CHEMBL1201526 Phase 4 Approuvé Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Technetium Tc 99m (pyro- and trimeta-) phosphates are mixed polyphosphate radiopharmaceutical preparations used for bone scintigraphy, with the pyrophosphate component also enabling myocardial imaging for detection of cardiac amyloidosis and acute myocardial infarction. The mixture of phosphate species provides bone-seeking properties through adsorption to hydroxyapatite in osteoblastic lesions. These formulations represent older generation bone and cardiac imaging agents.

Mécanisme d'action

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Technetium Tc 99m (pyro- and trimeta-) phosphates are mixed polyphosphate radiopharmaceutical preparations used for bone scintigraphy, with the pyrophosphate component also enabling myocardial imaging for detection of cardiac amyloidosis and acute myocardial infarction. The mixture of phosphate species provides bone-seeking properties through adsorption to hydroxyapatite in osteoblastic lesions. These formulations represent older generation bone and cardiac imaging agents.

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Yes, Technetium Tc 99M (Pyro- And Trimeta-) Phosphates is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201526. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.